The piggyBac (PB) transposon is one of the most useful transposable elements, and has been successfully used for genetic manipulation in more than a dozen species. However, the efficiency of PB-mediated transposition is still insufficient for many purposes. Here, we present a strategy to enhance transposition efficiency using a fusion of transcription activator-like effector (TALE) and the PB transposase (PBase). The results demonstrate that the TALE-PBase fusion protein which is engineered in this study can produce a significantly improved stable transposition efficiency of up to 63.9%, which is at least 7 times higher than the current transposition efficiency in silkworm. Moreover, the average number of transgene-positive individuals increased up to 5.7-fold, with each positive brood containing an average of 18.1 transgenic silkworms. Finally, we demonstrate that TALE-PBase fusion-mediated PB transposition presents a new insertional preference compared with original insertional preference. This method shows a great potential and value for insertional therapy of many genetic diseases. In conclusion, this new and powerful transposition technology will efficiently promote genetic manipulation studies in both invertebrates and vertebrates.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4660427 | PMC |
| http://dx.doi.org/10.1038/srep17172 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
A novel and efficient digital image steganography technique using least significant bit substitution.
Sci Rep
January 2025
Universidad Europea del Atlántico. Isabel Torres 21, Santander, 39011, Spain.
Steganography is used to hide sensitive types of data including images, audio, text, and videos in an invisible way so that no one can detect it. Image-based steganography is a technique that uses images as a cover media for hiding and transmitting sensitive information over the internet. However, image-based steganography is a challenging task due to transparency, security, computational efficiency, tamper protection, payload, etc.
View Article and Find Full Text PDFMetabolizable alloy clusters assemble nanoinhibitor for enhanced radiotherapy of tumor by hypoxia alleviation and intracellular PD-L1 restraint.
J Nanobiotechnology
December 2024
NHC Key Laboratory of Radiobiology, School of Public Health, Jilin University, Chang Chun, 130021, China.
Background: Cancer radiotherapy (RT) still has limited clinical success because of the obstacles including radioresistance of hypoxic tumors, high-dose X-ray-induced damage to adjacent healthy tissue, and DNA-damage repair by intracellular PD-L1 in tumor.
Results: Therefore, to overcome these obstacles multifunctional core-shell BMS@PtAu nanoparticles (NPs) are prepared using nanoprecipitation followed by electrostatic assembly. PtAu clusters are released from BMS@PtAu NPs to alleviate tumor hypoxia by catalyzing the decomposition of endogenous HO to generate O as well as by enhancing X-ray deposition at the tumor site, which thereby reduce the required X-ray dose.
Migratory Aryl Cross-Coupling.
J Am Chem Soc
January 2025
Department of Chemistry and Chemical Biology, Harvard University, 12 Oxford St., Cambridge, Massachusetts 02138, United States.
Article Synopsis
- Cross-coupling reactions are defined by regiospecificity, meaning the bond formation site is influenced by the position of the leaving group.
- Researchers propose a new method to create multiple structural isomers from the same coupling partners instead of synthesizing new isomer starting materials.
- The study demonstrates the use of a bulky palladium catalyst to enable efficient transposition of aryl halides, allowing high yields of unconventional product isomers through dynamic kinetic resolution combined with various nucleophiles.
DNA binding and transposition activity of the Sleeping Beauty transposase: role of structural stability of the primary DNA-binding domain.
Nucleic Acids Res
December 2024
Department of Physics and Optical Science, University of North Carolina at Charlotte, 9201 University City Blvd., Charlotte, NC 28223, USA.
DNA transposons have emerged as promising tools in both gene therapy and functional genomics. In particular, the Sleeping Beauty (SB) DNA transposon has advanced into clinical trials due to its ability to stably integrate DNA sequences of choice into eukaryotic genomes. The efficiency of the DNA transposon system depends on the interaction between the transposon DNA and the transposase enzyme that facilitates gene transfer.
View Article and Find Full Text PDFA novel hyperactive variant of the transposase facilitates non-viral genome engineering.
Mol Ther Nucleic Acids
December 2024
Research Center, Division of Hematology, Cell and Gene Therapy, Paul-Ehrlich-Institut, 63225 Langen, Germany.
Article Synopsis
- The SB transposon system is valuable for genetic applications like gene therapy, and a new hyperactive variant of the SB100X transposase, known as SB200X, was discovered with a specific amino acid change that increases its activity by about 2-fold.
- This hyperactivity is linked to an amino acid at position 124, located in the transposase's structural region, suggesting it can partially resist a regulatory mechanism called overproduction inhibition.
- Additionally, the Q124C variant not only boosts the efficiency of another variant (K248R) but also helps maintain a safer profile for genome-wide integration, making SB200X a promising tool for genome engineering in research and clinical settings.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!